Veeva Systems Operating Cash Flow decreased by 44.6% to $106.85M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 53.6%, from $69.54M to $106.85M. Over 4 years (FY 2022 to FY 2026), Operating Cash Flow shows an upward trend with a 16.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $478.39M | $119.07M | $112.96M | $54.05M | $481.03M | $93.39M | $142.66M | $63.40M | $505.94M | $265.04M | $82.60M | $57.77M | $763.52M | $92.87M | $164.12M | $69.54M | $877.16M | $238.43M | $192.79M | $106.85M |
| QoQ Change | — | -75.1% | -5.1% | -52.1% | +789.9% | -80.6% | +52.8% | -55.6% | +698.0% | -47.6% | -68.8% | -30.1% | >999% | -87.8% | +76.7% | -57.6% | >999% | -72.8% | -19.1% | -44.6% |
| YoY Change | — | — | — | — | +0.6% | -21.6% | +26.3% | +17.3% | +5.2% | +183.8% | -42.1% | -8.9% | +50.9% | -65.0% | +98.7% | +20.4% | +14.9% | +156.7% | +17.5% | +53.6% |